Home / general Neurocognitive impairment in euthymic patients with bipolar affective disorder - ePrints Abigail Rogers Updated on April 05, 2026 Neurocognitive impairment in euthymic patients with bipolar affective disorderLookup NU author(s): Jill Thompson,Dr Peter GallagherORCiD,Dr Stuart Watson,Dr John Gray,Emeritus Professor Nicol Ferrier,Professor Allan YoungDownloadsFull text for this publication is not currently held within this repository. Alternative links are provided below where available.AbstractBackground: Persistent impairments in neurocognitive function have been described in patients with bipolar disorder whose disease is in remission. However, methodological issues such as the effect of residual mood symptoms and hypercortisolaemia may confound such studies. Aims: To assess neurocognitive functioning in prospectively verified euthymic patients with bipolar disorder. Method: Sixty-three patients with bipolar disorder and a matched control group completed a comprehensive neurocognitive test battery. Euthymia was confirmed in the patient group by prospective clinical ratings over I month prior to testing. Saliva samples were collected to profile basal cortisol secretion. Results: Patients were significantly impaired across a broad range of cognitive domains. Across the domains tested, clinically significant impairment was observed in 3% to 42% of patients. Deficits were not causally associated with residual mood symptoms or hypercortisolaemia. Conclusions: Neurocognitive impairment persists in patients whose bipolar disorder is in remission. This may represent a trait abnormality and be a marker of underlying neurobiological dysfunction.Publication metadataAuthor(s): Thompson JM, Gallagher P, Hughes JH, Watson S, Gray JM, Ferrier IN, Young AHPublication type: ArticlePublication status: PublishedJournal: British Journal of PsychiatryYear: 2005Volume: 186Pages: 32-40Print publication date: 01/01/2005ISSN (print): 0007-1250ISSN (electronic): 1472-1465 Publisher: Royal College of PsychiatristsURL: DOI: 10.1192/bjp.186.1.32PubMed id: 15630121AltmetricsShare